BRPI0810996A2 - Composto, método para o tratamento de uma doença, uso de um composto, composição farmcêutica, e, kit. - Google Patents
Composto, método para o tratamento de uma doença, uso de um composto, composição farmcêutica, e, kit.Info
- Publication number
- BRPI0810996A2 BRPI0810996A2 BRPI0810996-6A2A BRPI0810996A BRPI0810996A2 BR PI0810996 A2 BRPI0810996 A2 BR PI0810996A2 BR PI0810996 A BRPI0810996 A BR PI0810996A BR PI0810996 A2 BRPI0810996 A2 BR PI0810996A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treatment
- kit
- disease
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical class C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 239000002740 neurokinin 3 receptor antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700620 | 2007-04-26 | ||
| PCT/DK2008/050092 WO2008131779A1 (en) | 2007-04-26 | 2008-04-24 | Isoquinolinone derivatives as nk3 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0810996A2 true BRPI0810996A2 (pt) | 2015-01-27 |
Family
ID=43034539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0810996-6A2A BRPI0810996A2 (pt) | 2007-04-26 | 2008-04-24 | Composto, método para o tratamento de uma doença, uso de um composto, composição farmcêutica, e, kit. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2150534B1 (pt) |
| JP (1) | JP2010524980A (pt) |
| CN (1) | CN101679276A (pt) |
| AT (1) | ATE540929T1 (pt) |
| AU (1) | AU2008243514A1 (pt) |
| BR (1) | BRPI0810996A2 (pt) |
| CA (1) | CA2683159A1 (pt) |
| EA (1) | EA200971002A1 (pt) |
| ES (1) | ES2378911T3 (pt) |
| MX (1) | MX2009011541A (pt) |
| NZ (1) | NZ580637A (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102076820B1 (ko) | 2013-10-21 | 2020-02-13 | 주식회사 대웅테라퓨틱스 | 신규한 항진균성 옥소다이하이드로피리딘카보하이드라자이드 유도체 |
| JP6623220B2 (ja) * | 2014-11-03 | 2019-12-18 | バイエル ファーマ アクチエンゲゼルシャフト | ヒドロキシアルキル置換フェニルトリアゾール誘導体およびその使用 |
| CN114605236B (zh) * | 2022-03-16 | 2023-12-29 | 福建省中科生物股份有限公司 | 联芳基酚类化合物及其药物组合物、制备方法和应用 |
-
2008
- 2008-04-24 NZ NZ580637A patent/NZ580637A/en unknown
- 2008-04-24 EA EA200971002A patent/EA200971002A1/ru unknown
- 2008-04-24 ES ES08734547T patent/ES2378911T3/es active Active
- 2008-04-24 JP JP2010504454A patent/JP2010524980A/ja not_active Withdrawn
- 2008-04-24 BR BRPI0810996-6A2A patent/BRPI0810996A2/pt not_active IP Right Cessation
- 2008-04-24 MX MX2009011541A patent/MX2009011541A/es not_active Application Discontinuation
- 2008-04-24 AU AU2008243514A patent/AU2008243514A1/en not_active Abandoned
- 2008-04-24 CA CA002683159A patent/CA2683159A1/en not_active Abandoned
- 2008-04-24 CN CN200880013510A patent/CN101679276A/zh active Pending
- 2008-04-24 AT AT08734547T patent/ATE540929T1/de active
- 2008-04-24 EP EP08734547A patent/EP2150534B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010524980A (ja) | 2010-07-22 |
| MX2009011541A (es) | 2009-11-09 |
| EA200971002A1 (ru) | 2010-04-30 |
| EP2150534B1 (en) | 2012-01-11 |
| CN101679276A (zh) | 2010-03-24 |
| NZ580637A (en) | 2011-07-29 |
| CA2683159A1 (en) | 2008-11-06 |
| AU2008243514A1 (en) | 2008-11-06 |
| EP2150534A1 (en) | 2010-02-10 |
| ES2378911T3 (es) | 2012-04-19 |
| ATE540929T1 (de) | 2012-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP099414A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa | |
| EA200801551A1 (ru) | Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы | |
| CL2007002641A1 (es) | Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias. | |
| UY30098A1 (es) | Compuestos de tiazol y metodos de uso | |
| ECSP088902A (es) | Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios | |
| ECSP11011082A (es) | Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos | |
| BRPI0917138A2 (pt) | composto, métodos para tratar doenças alérgicas e outras condições inflamatórias, rinite alérgica, e para tratar ou prevenir doença, composição farmacêutica, uso de um composto, e, combinação. | |
| CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
| ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
| NO20080408L (no) | Azaindazolforbindelser og anvendelse derav | |
| CL2010001348A1 (es) | Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad. | |
| CL2010001483A1 (es) | Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune. | |
| UY30468A1 (es) | Compuestos quimicos. | |
| EA201000091A1 (ru) | ПРОИЗВОДНЫЕ МОРФОЛИНОПИРИМИДИНА, ИСПОЛЬЗУЕМЫЕ ПРИ ЗАБОЛЕВАНИЯХ, СВЯЗАННЫХ С mTOR КИНАЗОЙ И/ИЛИ PI3K | |
| EA200870409A1 (ru) | Антагонисты киназы pi3 | |
| BRPI0811816A2 (pt) | "forma de dosagem de picoplatina estabilizada, método para preparar uma forma de dosagem de picoplatina estabilizada, composições, kit, pluralidade de kits, método para tratamento de câncer e uso de uma quantidade eficaz da forma de dosagem" | |
| BRPI0606112A2 (pt) | 3 - heteroaril - 3 - hidróxi - 2 - amino - propil aminas e compostos relacionados, bem como uso dos mesmos e composição farmacêutica | |
| AR074379A1 (es) | Inhibidor de triazolotiadiazola de la proteina quinasa c-met | |
| EA201401231A1 (ru) | Фармацевтические комбинации, предназначенные для лечения метаболических нарушений | |
| ATE502935T1 (de) | C-met-proteinkinasehemmer | |
| ITVA20060041A1 (it) | Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington | |
| BRPI0513944A (pt) | forma substancialmente pura de um composto de quinazolina, uso de um composto de quinazolina e composição | |
| UY30424A1 (es) | Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos. | |
| BRPI0810996A2 (pt) | Composto, método para o tratamento de uma doença, uso de um composto, composição farmcêutica, e, kit. | |
| SV2010003773A (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |